Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Atossa Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 86 | 2 | 86 | +2 |
| Shares | 27.3M | 11.8K | 29.9M | +2.60M (+9.5%) |
| Value | $41.6M | $18.0K | $28.3M | −$13.3M (−32.0%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Atossa Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 31,501 | $29.0K | 0.00% |
| Millennium Management LLC | 29,149 | $27.5K | 0.00% |
| Gallagher Capital Advisors, LLC | 26,075 | $24.6K | 0.02% |
| Police & Firemen's Retirement System of New Jersey | 25,430 | $24.0K | 0.00% |
| Raymond James Financial Inc | 18,815 | $17.8K | 0.00% |
| Group One Trading, L.P. | 13,430 | $12.7K | 0.00% |
| CIBC World Markets Corp | 11,837 | $11.2K | 0.00% |
| SBI Securities Co., Ltd. | 1,565 | $1.48K | 0.00% |
| R Squared Ltd | 1,020 | $963 | 0.00% |
| EverSource Wealth Advisors, LLC | 32 | $30 | 0.00% |
| Simplex Trading, LLC | 609 | $0 | 0.00% |
Sold out (9)
Institutions that held Atossa Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Wolverine Trading, LLC | 30,922 | $46.7K |
| MetLife Investment Management | 23,978 | $36.4K |
| Acadian Asset Management LLC | 14,586 | $22.0K |
| Squarepoint Ops LLC | 12,627 | $19.2K |
| Principal Financial Group Inc | 10,245 | $15.6K |
| Silicon Valley Capital Partners | 3,875 | $5.89K |
| Signaturefd, LLC | 400 | $608 |
| Delos Wealth Advisors, LLC | 100 | $152 |
| Capital Performance Advisors LLP | 25 | $38 |
Not filed for Q4 2024 yet (2)
Institutions that held Atossa Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 10,815 | $16.4K |
| Planning Capital Management Corp | 1,000 | $1.52K |